Evidence map›Paper›PMID 38936925›Full record

ArticleIn vivo (Athens, Greece)

Body Composition in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease: Impact of Body Surface Area.

Saori Onishi, Akira Fukuda, Masahiro Matsui, Kosuke Ushiro, Tomohiro Nishikawa, Akira Asai, Soo Ki Kim, Hiroki Nishikawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Saori OnishiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Akira FukudaOsaka Medical and Pharmaceutical University Health Science Clinic, Osaka, Japan.
Masahiro MatsuiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Kosuke UshiroSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Tomohiro NishikawaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Akira AsaiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Soo Ki KimDepartment of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan.
Hiroki NishikawaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan; hiroki.nishikawa@ompu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimTo examine the relationship between the body surface area (BSA) and body composition in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, 2,141 men and 986 women). MATERIALS AND

methodsBSA and body composition parameters were examined.

resultsThe median body mass index (BMI) was 25.0 kg/m

conclusionBSA could be a useful marker for the estimation of body composition in patients with MASLD.

Indexed as

Body CompositionBody Mass IndexBody Surface AreaAdultAgedFatty LiverFemaleHumansMaleMetabolic DiseasesMiddle Agedbody compositionfat-free massfat massMetabolic dysfunction-associated steatotic liver disease

Identifiers

PMID38936925
PMCPMC11215608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.